Literature DB >> 19059199

Action mechanism and structural requirements of the antimicrobial peptides, gaegurins.

Hyung-Sik Won1, Su-Jin Kang, Bong-Jin Lee.   

Abstract

Gaegurins (GGNs) are a family of cationic, alpha-helical, antimicrobial peptides that were isolated from a Korean frog, Glandirana emeljanovi (formerly classified as Rana rugosa) and represent one of the structurally well-characterized groups. Among six gaegurins, gaegurin 4 (renamed herein esculentin-2EM), gaegurin 5 (brevinin-1EMa), and gaegurin 6 (brevinin-1EMb) have been investigated comprehensively in terms of structure-activity relationships. In this paper, we first suggest renaming of gaegurins according to a recently raised rule of systematic nomenclature. Then, the current understanding of gaegurins is reviewed by summarizing their structure-activity relationships. In particular competing arguments on gaegurins are synthetically inspected. Finally their action mechanism and structural requirements will be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059199     DOI: 10.1016/j.bbamem.2008.10.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide.

Authors:  Hyung-Sik Won; Su-Jin Kang; Wahn-Soo Choi; Bong-Jin Lee
Journal:  Mol Cells       Date:  2010-11-23       Impact factor: 5.034

2.  Mechanisms of selective antimicrobial activity of gaegurin 4.

Authors:  Heejeong Kim; Byeong Jae Lee; Mun Han Lee; Seong Geun Hong; Pan Dong Ryu
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-20       Impact factor: 2.016

Review 3.  pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents.

Authors:  Erum Malik; Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Pharmaceuticals (Basel)       Date:  2016-11-01

4.  Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential.

Authors:  Yangyang Jiang; Yue Wu; Tao Wang; Xiaoling Chen; Mei Zhou; Chengbang Ma; Xinping Xi; Ying Zhang; Tianbao Chen; Chris Shaw; Lei Wang
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 5.  Host Defense Peptides from Asian Frogs as Potential Clinical Therapies.

Authors:  Vineeth T V Kumar; David Holthausen; Joshy Jacob; Sanil George
Journal:  Antibiotics (Basel)       Date:  2015-03-30

6.  Small Cationic Peptides: Influence of Charge on Their Antimicrobial Activity.

Authors:  José Javier López Cascales; Siham Zenak; José García de la Torre; Osvaldo Guy Lezama; Adriana Garro; Ricardo Daniel Enriz
Journal:  ACS Omega       Date:  2018-05-18

Review 7.  Antimicrobial peptides for therapeutic applications: a review.

Authors:  Min-Duk Seo; Hyung-Sik Won; Ji-Hun Kim; Tsogbadrakh Mishig-Ochir; Bong-Jin Lee
Journal:  Molecules       Date:  2012-10-18       Impact factor: 4.411

8.  Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.

Authors:  Seo-Jin Kim; Jae-Seok Kim; Yoo-Sup Lee; Dae-Won Sim; Sung-Hee Lee; Young-Yil Bahk; Kwang-Ho Lee; Eun-Hee Kim; Sung-Jean Park; Bong-Jin Lee; Hyung-Sik Won
Journal:  Molecules       Date:  2013-01-11       Impact factor: 4.411

9.  Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri.

Authors:  Xiaowei Zhou; Yue Liu; Yitian Gao; Yuanxing Wang; Qiang Xia; Ruimin Zhong; Chengbang Ma; Mei Zhou; Xinping Xi; Chris Shaw; Tianbao Chen; Di Wu; Hang Fai Kwok; Lei Wang
Journal:  Toxins (Basel)       Date:  2020-07-30       Impact factor: 4.546

10.  Linearized esculentin-2EM shows pH dependent antibacterial activity with an alkaline optimum.

Authors:  Erum Malik; David A Phoenix; Timothy J Snape; Frederick Harris; Jaipaul Singh; Leslie H G Morton; Sarah R Dennison
Journal:  Mol Cell Biochem       Date:  2021-06-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.